Lutetium-177 (Lu-177) Radioligand Therapy
What's included in this package
Medical Procedures
- Lutetium-177 therapy
- Consultation with a doctor
Duration
- 1 days in the hospital
Accommodation
Accommodation is not included
Transport
VIP transfer (premium vehicle service, all transfers between airport, hotel and clinic)
Additional information
Lutetium-177 (Lu-177) Radioligand Therapy
Lutetium-177 therapy is a targeted radionuclide treatment in which a radioactive substance linked to a specific molecule binds to cancer cells and delivers radiation directly to them. The treatment is administered intravenously under the supervision of a Nuclear Medicine specialist, with monitoring before and after the procedure to ensure safety and treatment effectiveness.
Package Includes:
Nuclear Medicine specialist consultation
Required laboratory tests and medical evaluation
Lutetium-177 treatment administration
Radiation safety monitoring
Post-treatment medical assessment
Follow-up recommendations
Treatment Duration: According to the patient's clinical condition and treatment protocol
Hospitalization: As required by the nuclear medicine team and radiation safety regulations
24/7 Bookimed assistance
- Personal medical coordinator
- Medical travel arrangements — booking of air tickets and hotel rooms at special partner prices
- Patient advocacy during medical travel
Programme price
special price valid till 7 November 2026
What's NOT included in this package
Doctor
Dr. Tamer Aksoy is a nuclear medicine specialist at Hisar Hospital Intercontinental in Istanbul. He specializes in PET/CT examinations and radionuclide therapies. Dr. Aksoy completed clinical research as an observer at the Netherlands Cancer Institute in Amsterdam. He holds the title of Associate Professor.
- Member of the European Association of Nuclear Medicine.
- Expert in PET/CT imaging using Gallium 68 for precise diagnostics.
- Focuses on radionuclide therapy for oncology patients.
- Works at Hisar Hospital, which holds JCI accreditation for safety and quality.
How are we doing?
About the clinic
Lutetium-177 therapy is a targeted radionuclide treatment for advanced prostate cancer available at Hisar Hospital Intercontinental in Istanbul, Turkey. A single session may cost around $8,800, with a complete package including diagnostics and consultation typically running $9,600-9,700. The hospital is JCI-accredited through 2027, and treatment is supervised by Assoc. Prof. Dr. Tamer Aksoy, a nuclear medicine specialist with 26 years of experience.
About the Treatment
Lutetium-177 therapy uses radioligands that bind to PSMA receptors on prostate cancer cells. It is designed for cases resistant to other treatments. Patients usually complete 6-8 sessions spaced 8-9 weeks apart.
What's Included
- Lutetium-177 therapy per session
- Doctor consultation ($160 value)
- PET-CT Ga-68 PSMA imaging ($720)
- 1-2 nights hospitalization with meals
- Personal assistance and translation services
- Transport between airport, hotel, and clinic
Medical Team
Assoc. Prof. Dr. Tamer Aksoy leads the treatment with 900+ procedures performed. Trained at Netherlands Cancer Institute, he monitors progress using Ga-68 imaging between sessions. This allows personalized adjustments to each patient's therapy.
Hospital Features
Hisar Hospital maintains a 4.4/5 rating from 172 patients. The JCI accreditation confirms international safety standards. Multilingual staff provide support in 8 languages including English and Arabic.
Patients receive same-day ambulatory care after treatment with 1-2 nights of monitoring. The hospital can help arrange nearby accommodations for those traveling to Istanbul for therapy.
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with instalment options.
Earn rewards for referring friends to Bookimed.